Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1999Journal of Clinical Oncology

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JNJean‐Marc NabholtzAstraZeneca (United Kingdom)HSH.-J. SennUniversity of St.GallenWBW.R. BezwodaUniversity of the Witwatersrand

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nabholtz et al. (1999) studied this question.

synapsesocial.com/papers/6a1bc421b33628da419cd2bchttps://doi.org/10.1200/jco.1999.17.5.1413
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Docetaxel: a new active agent in the therapy of metastatic breast cancer1997 · 23 citations
  2. 2Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.1995 · 120 citations
  3. 3Modelling for Survival Data in Medical Research1995 · 2,163 citations